Novartis, Amgen and Mallinckrodt used aggressive price hikes to meet sales goals, congressional probe finds — Alnylam posts positive results of groundbreaking phase 3 PH1 trial — FDA expands probe into safety of AstraZeneca's COVID vaccine — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page

Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.